The Value Line Investment Survey (Part 3 - Ratings & Reports) 2007 Keith A. Markey - Abstracts
| The Value Line Investment Survey (Part 3 - Ratings & Reports) 2007 Keith A. Markey | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Allergan, Inc.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| Amgen.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| Biotechnology industry.(analysis of securities) | Business, general | George Rho, Charles Clark, Keith A. Markey, Randy Shrikishun, Andre J. Costanza, Susan J. Ferrara, Jerry W. Gray, John D. Burke | |||
| Biotechnology industry.(analysis of securities) | Business, general | George Rho, Charles Clark, Keith A. Markey, Randy Shrikishun, Andre J. Costanza, Susan J. Ferrara, Jerry W. Gray, Nira Maharaj | |||
| Biotechnology industry.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| Celgene Corp.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| Charles River Lab.(stock price appreciation potential; Charles River Laboratories) | Business, general | Keith A. Markey | |||
| CryoLife Inc.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| Cyberonics Inc.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| Drug industry. | Business, general | George Rho, Sigourney B. Romaine, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, J. Susan Ferrara, Frederick L. Harris, Erik A. Antonson, Michael F. Napoli, Douglas G. Maurer | |||
| Drug industry.(analysis of securities) | Business, general | George Rho, Sigourney B. Romaine, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, Frederick L. Harris, Susan J. Ferrara, Erik A. Antonson, Michael F. Napoli, Douglas G. Maurer | |||
| Drug industry.(securities analysis as of July 20, 2007)(Industry overview) | Business, general | George Rho, Mario Ferro, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, J. Susan Ferrara, Frederick L. Harris, William C. Lewittes | |||
| Genentech, Inc.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| Haemonetics Corp.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| Haemonetics Corp.(stock price appreciation potential)(Analyst report) | Business, general | Keith A. Markey | |||
| Kinetic Concepts.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| Kinetic Concepts.(stock price appreciation potential)(Analyst report) | Business, general | Keith A. Markey | |||
| Medical supplies industry.(analysis of securities) | Business, general | Kenneth A. Nugent, George Rho, Keith A. Markey, Nils C. Van Liew, Andre J. Costanza, Iason Dalavagas, Erik A. Antonson, Greg McGowan, Tom Nikic, Christopher Robertson, Jerry W. Gray | |||
| Medical supplies industry.(investment considerations) | Business, general | Keith A. Markey | |||
| Medical supplies industry.(securities' industry) | Business, general | Kenneth A. Nugent, George Rho, Keith A. Markey, Nils C. Van Liew, Andre J. Costanza, Iason Dalavagas, Erik A. Antonson, Greg McGowan, Tom Nikic, Christopher Robertson, Jerry W. Gray | |||
| Medical supplies industry.(stock price appreciation potential)(Analyst report) | Business, general | Keith A. Markey | |||
| Myriad Genetics.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| Neurocrine Biosci.(stock price appreciation potential; Neurocrine Biosciences Inc.) | Business, general | Keith A. Markey | |||
| NitroMed, Inc.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| NPS Pharm., Inc.(stock price appreciation potential of NPS Pharmaceuticals, Inc.) | Business, general | Keith A. Markey | |||
| PAREXEL Intl Corp.(stock price appreciation potential; PAREXEL International Corp.) | Business, general | Keith A. Markey | |||
| Perrigo Co.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| Techne Corp.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| Thoratec Corp.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
| XenoPort, Inc.(stock price appreciation potential) | Business, general | Keith A. Markey | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.